Skip to main content

Peer Review reports

From: An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Original Submission
18 Oct 2020 Submitted Original manuscript
28 Mar 2021 Reviewed Reviewer Report - Floris Schreuder
28 Mar 2021 Reviewed Reviewer Report - Kirsty Loudon
1 Apr 2021 Reviewed Reviewer Report - Frank Wolters
20 Jun 2021 Author responded Author comments - Arjune Sen
Resubmission - Version 2
20 Jun 2021 Submitted Manuscript version 2
22 Jun 2021 Reviewed Reviewer Report - Frank Wolters
23 Jun 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jun 2021 Editorially accepted
31 Jul 2021 Article published 10.1186/s13063-021-05404-4

You can find further information about peer review here.

Back to article page